» Articles » PMID: 21484860

Hypertrophy of Ligamentum Flavum in Lumbar Spine Stenosis Associated with the Increased Expression of Connective Tissue Growth Factor

Overview
Journal J Orthop Res
Publisher Wiley
Specialty Orthopedics
Date 2011 Apr 13
PMID 21484860
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertrophy of the ligamentum flavum (LF) contributes to lumbar spinal stenosis (LSS), and results mainly from fibrosis. Connective tissue growth factor (CTGF) is a profibrotic factor involved in the fibrotic process. This study aimed to evaluate CTGF expression in hypertrophied lumbar LF and the involvement of CTGF in LF hypertrophy. Ten patients with LSS were enrolled in this study. The control group included 10 patients with lumbar disc herniation. LF thickness was measured on the preoperative axial T1-weighted MRI. LF samples were collected during surgery. LF fibrosis was scored by Masson's trichrome staining. CTGF expression was determined by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry. Correlation between LF thickness and CTGF expression was analyzed. Human LF cells were cultured and treated with recombinant human (rh) CTGF. Expression of types I and III collagen was determined by real-time PCR and ELISA. The thickness and fibrosis scores of LF in the LSS group were higher than that in the control group (all P < 0.001). CTGF was expressed in the extracellular matrix of all ligament samples, and was significantly higher in the LSS group than that in the control group (P < 0.001). The increase of CTGF expression was positive correlation with the LF thickness (r = 0.969, P = 0.000). rhCTGF treatment increased the mRNA expression and protein synthesis of types I and III collagen of the LF cells (all P < 0.001). Our results suggest that the increased expression of CTGF is associated with hypertrophy of the LF in patients with LSS.

Citing Articles

Single-cell multi-omics analysis identifies SPP1 macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy.

Fei C, Chen Y, Tan R, Yang X, Wu G, Li C Biomark Res. 2025; 13(1):33.

PMID: 40001138 PMC: 11863437. DOI: 10.1186/s40364-025-00746-6.


Cellular and Molecular Mechanisms of Hypertrophy of Ligamentum Flavum.

Silwal P, Nguyen-Thai A, Alexander P, Sowa G, Vo N, Lee J Biomolecules. 2024; 14(10).

PMID: 39456209 PMC: 11506588. DOI: 10.3390/biom14101277.


Macrophage polarization and macrophage-related factor expression in hypertrophy of the ligamentum flavum.

Jiang C, Wang W, Chen Y, Chen J, Zhang Z, Li J Eur Spine J. 2024; 33(12):4476-4487.

PMID: 39375228 DOI: 10.1007/s00586-024-08513-1.


Evaluation of differences in expression pattern of three isoforms of the transforming growth factor beta in patients with lumbosacral stenosis.

Sobanski D, Bogdal P, Staszkiewicz R, Sobanska M, Filipowicz M, Czepko R Cell Cycle. 2024; 23(5):555-572.

PMID: 38695374 PMC: 11135850. DOI: 10.1080/15384101.2024.2345484.


Exploring lncRNA Expression Patterns in Patients With Hypertrophied Ligamentum Flavum.

Chen J, Zhong G, Qiu M, Ke W, Xue J, Chen J Neurospine. 2024; 21(1):330-341.

PMID: 38291747 PMC: 10992663. DOI: 10.14245/ns.2346994.497.